38.52
-0.30
(-0.77%)
Jun 19 - Close
NASDAQ
real-time data -
Disclaimer
Currency in USD
| Range | 38.52 - 39.20 |
| 52 week | 25.00 - 39.82 |
| Open | 38.74 |
| Vol / Avg. | 1.09M/2.34M |
| Mkt cap | 4.32B |
| P/E | - |
| Div/yield | - |
| EPS | -5.69 |
| Shares | 112.24M |
| Beta | 0.74 |
| Inst. own | 105% |
Events
Aug 5, 2013
Q2 2013 Endo Health Solutions Inc. Earnings Release
Jun 5, 2013
Endo Health Solutions Update -
May 22, 2013
Endo Health Solutions Inc. Annual Shareholder Meeting
May 7, 2013
Q1 2013 Endo Health Solutions Inc. Earnings Conference Call -
Apr 29, 2013
Q1 2013 Endo Health Solutions Inc. Earnings Release
|
More events from DailyFinance »
|
Key stats and ratios
| Q1 (Mar '13) | 2012 | |
| Net profit margin | 3.75% | -22.73% |
| Operating margin | 11.56% | -18.46% |
| EBITD margin | - | 38.14% |
| Return on average assets | 1.65% | -9.93% |
| Return on average equity | 5.63% | -48.54% |
| Employees | 4,566 | - |
| Carbon Disclosure Rating | - | - |
Address
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
Discussion Group - Google Finance
Volume delayed by 15 mins.
Advertisement
Description
Endo Health Solutions Inc. is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm , Opana ER, Voltaren Gel, Percocet , Frova , Supprelin LA, Vantas , Valstar and Fortesta Gel. The Company operates in four segments: Endo Pharmaceuticals, Qualitest, AMS, and HealthTronics. Through the Company's HealthTronics segment, the Company provides lithotripsy services, prostate treatment services, anatomical pathology services, medical products manufacturing, sales and maintenance, and information technology solutions. Its products in the Qualitest portfolio includes Endocet, Morphine Sulfate ER, and Hydrocodone. Its AMS products include AMS 700 MS, AMS 800 artificial urinary sphincter, GreenLight XPS laser system, and Monarc subfascial hammock. Its Endo Pharmaceuticals products include Lidoderm, Opana ER, Voltaren Gel, and Percocet.
Officers and directors
| Roger H. Kimmel | Independent Chairman of the Board | |
| Rajiv De Silva | President, Chief Executive Officer, Director | |
| Alan G. Levin | Chief Financial Officer, Executive Vice President | |
| Camille Farhat | President of American Medical Systems Inc. | |
| Ivan P. Gergel M.D. | Executive Vice President - Research & Development, Chief Scientific Officer | |
| Caroline B. Manogue | Executive Vice President, Chief Legal Officer, Secretary | |
| John J DeLucca | Independent Director | |
| Nancy J. Hutson Ph.D. | Independent Director | |
| Michael Hyatt | Independent Director | |
| William P. Montague | Independent Director |